Achillion Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two upcoming investor conferences:
Help employers find you! Check out all the jobs and post your resume.